Six weeks later, my chronic shoulder issue thats plagued me for three years is 80% better, my gut finally works properly, and Im recovering from training faster than I did in my twenties
Animal studies have suggested its potential in supporting tissue repair processes in muscle, tendon, and torn ligaments
Both candidates are designed to move beyond single-pathway GLP-1 therapy, but they take very different routes: CagriSema combines an amylin analog with semaglutide, while Retatrutide compresses GIP, GLP-1, and glucagon agonism into one investigational peptide
Its important to note that while peptides are not FDA-approved, they have been used in research and clinical settings with excellent results
Cagrilintide holds promise as a tool for long-term weight management, offering an alternative or complement to other weight loss treatments, including lifestyle changes and surgery